Lisett Contreras

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

Pharmacological reports : PR

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Robles-Escajeda, Jonathon Edward Mohl, Lisett Contreras, Ana P Betancourt, Bibiana M Mancera, Robert A Kirken, Georgialina Rodriguez
Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex. Viruses 15 (3) (2023)
Elisa Robles-Escajeda, Jonathon Edward Mohl, Lisett Contreras, Ana P Betancourt, Bibiana M Mancera, Robert A Kirken, Georgialina Rodriguez
Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex. Viruses 15 (3) (2023)
Elisa Robles-Escajeda, Jonathon Edward Mohl, Lisett Contreras, Ana P Betancourt, Bibiana M Mancera, Robert A Kirken, Georgialina Rodriguez
Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex. Viruses 15 (3) (2023)
Denisse A Gutierrez, Lisett Contreras, Paulina J Villanueva, Edgar A Borrego, Karla Selene Morán-Santibáñez, Jessica D Hess, Rebecca DeJesus, Manuel Larragoity, Ana P Betancourt, Jonathon Edward Mohl, Elisa Robles-Escajeda, Khodeza Begum, Sourav Roy, Robert A Kirken, Armando Varela-Ramirez, Renato J Aguilera
Identification of a Potent Cytotoxic Pyrazole with Anti-Breast Cancer Activity That Alters Multiple Pathways. Cells 11 (2) (2022)
Lisett Contreras, Stephanie Medina, Austre Y Schiaffino Bustamante, Edgar A Borrego, Carlos A Valenzuela, Umashankar Das, Subhas S Karki, Jonathan R Dimmock, Renato J Aguilera
Three novel piperidones exhibit tumor-selective cytotoxicity on leukemia cells via protein degradation and stress-mediated mechanisms. Pharmacological reports : PR (2021)